List view / Grid view
28 November 2011 | By Abbott
Abbott announced that it will expand its existing agreement with GSK...
28 November 2011 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced that the European Commission has granted marketing authorization for Eviplera®...
23 November 2011 | By kdm communications limited
Syrris is pleased to announce the release of its new Asia flow chemistry reactors catalogue...
23 November 2011 | By Weizmann UK
The clinical trial was random, regulated, double-blinded and broad-based...
22 November 2011 | By Pfizer
Lead program includes novel investigational compound for prevention/treatment of skin scarring...
22 November 2011 | By H. Lundbeck A/S (Lundbeck)
H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced today that the US Food and Drug Administration (FDA) has determined that a new drug application (NDA) for Otsuka's investigational once-monthly aripiprazole depot formulation for the indication of maintenance treatment of schizophrenia in adults is sufficiently complete to permit…
22 November 2011 | By kdm communications limited
Donation of a Tecan Sunrise™ microplate reader to Mongolian medical researchers, assisting their studies of vitamin D levels in the general population...
22 November 2011 | By Merck
Merck has reached a resolution with federal and state authorities regarding a previously disclosed investigation concerning Vioxx...
21 November 2011 | By Pfizer
10-year lease marks a strategic partnership between the academic research community and industry to boost innovation...
21 November 2011 | By Gilead Sciences
Gilead Sciences, Inc., will acquire Pharmasset, Inc., for $137 per share in cash...
21 November 2011 | By Abbott
Abbott received approval from the U.S. FDA for a new Chagas in vitro diagnostic test...
21 November 2011 | By Pfizer
Pfizer Inc. announced that its Market Authorisation Application for tofacitinib...
18 November 2011 | By Roche
FDA Commissioner revokes approval of Avastin for treatment of mBC in the US...
18 November 2011 | By AstraZeneca
CAPRELSA receives a positive opinion...
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
